As Profits Rise, Ocular Science Promotes From Within

Ocular Science, which produces and markets ophthalmic formulations for post-op cataract and LASIK procedures, glaucoma management, myopia control and dry eye disease, has promoted Eric Garner to Vice President of Marketing.

Ocular Science Taps Ophthalmology Medical Device Pro to Lead U.S. Sales

Ocular Science®, which produces and markets ophthalmic formulations for post-op cataract and LASIK procedures, glaucoma management, myopia control and dry eye disease, has named Greg Anderson as its vice president of sales.

Simplify Drop Use

It is agreed that controlling inflammation and managing infection risk, via steroids and NSAIDS and antibiotics, respectively, are of monumental importance following cataract surgery.

Ocular Science Launches Two Affiliates to Focus on Compounding and Biologic Sectors

Ocular Science launches two affiliates to focus on compounding and biologic sectors of ophthalmic market.

ASCRS FDA Committee Member Speaks on Access to Compounded Drugs

ASCRS FDA committee member Damien Goldberg, MD, urges FDA to allow access to compounded drugs from traditional compounders without a patient-specific prescription.